Causes of Multiple Sclerosis
User reported causes of Multiple Sclerosis based on their intuition.
Cause | Agree |
---|---|
Stress | 89% |
Heat | 78% |
Neurological | 69% |
Compromised Immune System | 58% |
Low Vitamin D Level | 53% |
Environmental | 48% |
Fever | 46% |
Virus/Sickness Triggers Relapse | 44% |
Possibly Born With the Illness / Genetic Predisposition | 43% |
High Humidity | 40% |
Weather/Seasonal Changes | 39% |
Difficulties at Work | 37% |
Western Diet | 33% |
Epstein Barr Virus | 30% |
Dehydration | 28% |
Physical Trauma | 27% |
Pshychological Trauma | 27% |
USA Vegetables Being Vitamin Depleted | 23% |
Sugar Addiction | 18% |
Chronic Cerebrospinal Venous Insufficiency (CCSVI) | 18% |
Growth Hormones in Meats | 18% |
Caregiving to Family Member | 17% |
Vaccination | 17% |
Surgery | 15% |
Auto Accident | 15% |
Lyme Disease And/or Co-Infections | 13% |
Post-Traumatic Stress Disorder (PTSD) | 10% |
Repeated Head Trauma | 10% |
Death of Child | 8% |
Hepatitis Vaccination or Booster | 8% |
Death of Spouse | 6% |
Purpera | 2% |
Conditions Resulting from Multiple Sclerosis
User-reported conditions resulting from Multiple Sclerosis based on their intuition.
Resulting Condition | Agree |
---|---|
Herniated Disc | 87% |
Plantar Fasciitis | 70% |
Chronic Cerebrospinal Venous Insufficiency (CCSVI) | 49% |
Urinary Incontinence | 21% |
Neurological Problems and Chronic Pain | 18% |
Vertigo | 16% |
Neuropathy | 14% |
Chronic Pain Syndrome | 7% |
Constipation | 6% |
Dizziness/Lightheadedness | 6% |
Myofascial Pain Syndrome | 5% |
Athlete's Foot | 5% |
Scoliosis | 5% |
Night Cramps | 5% |
Hearing Loss | 5% |
Cold Intolerance | 5% |
Chronic Fatigue Syndrome | 4% |
Fatigue | 4% |
Depression | 3% |
Rheumatoid Arthritis | 3% |
Shoulder Pain | 3% |
Tinnitus | 3% |
Neck Pain | 3% |
Back Pain | 2% |
Lower Back Pain | 2% |
Allergies | 1% |
Anxiety / Nervousness | 1% |
Infertility | 0% |
Occipital Neuritis | 0% |
Treatments
User-reported effectiveness in treating Multiple Sclerosis
Treatment | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
---|---|---|---|---|---|---|
Physical Therapy | 13% | 49% | 0% | 30% | 8% | 106 |
Rest | 22% | 52% | 0% | 22% | 3% | 203 |
Exercise | 19% | 43% | 3% | 29% | 6% | 193 |
Acupuncture | 2% | 32% | 7% | 54% | 5% | 41 |
Low Dose Naltrexone (LDN) | 50% | 32% | 2% | 14% | 3% | 125 |
Neurontin (Gabapentin) | 11% | 38% | 8% | 38% | 5% | 61 |
Corticosteroids | 23% | 45% | 6% | 21% | 6% | 107 |
Vitamin D | 9% | 22% | 1% | 66% | 2% | 125 |
Provigil | 19% | 37% | 11% | 27% | 5% | 62 |
Massage Therapy | 22% | 46% | 0% | 28% | 4% | 46 |
Trigger Point Injections | 17% | 50% | 0% | 17% | 17% | 6 |
Paracetamol | 0% | 37% | 0% | 60% | 3% | 30 |
Baclofen | 16% | 24% | 3% | 46% | 11% | 79 |
Xanax | 17% | 33% | 6% | 39% | 6% | 18 |
Occupational Therapy | 7% | 36% | 5% | 48% | 5% | 42 |
Estrogen Therapy | 13% | 25% | 13% | 50% | 0% | 8 |
Chinese Herbs | 5% | 25% | 5% | 65% | 0% | 20 |
Homeopathy | 15% | 20% | 0% | 60% | 5% | 20 |
Cannabis | 23% | 40% | 4% | 28% | 4% | 47 |
Diet Changes | 17% | 38% | 2% | 39% | 3% | 180 |
Tysabri | 21% | 21% | 14% | 41% | 3% | 29 |
Copaxone | 9% | 19% | 4% | 60% | 9% | 112 |
Counseling | 14% | 45% | 2% | 33% | 7% | 58 |
Ayurveda | 0% | 100% | 0% | 0% | 0% | 4 |
Celexa | 8% | 33% | 0% | 33% | 25% | 12 |
Avonex | 3% | 11% | 28% | 48% | 9% | 64 |
Pool, Water Therapy | 23% | 57% | 0% | 13% | 7% | 30 |
IV Steroids | 29% | 38% | 6% | 22% | 5% | 82 |
Acupressure | 15% | 77% | 0% | 8% | 0% | 13 |
Intravenous Solution (Calcium-EAP) | 75% | 0% | 0% | 25% | 0% | 4 |
Gilenya | 50% | 50% | 0% | 0% | 0% | 4 |
Grain/legume/dairy-Free Diet (Aka Paleo) | 20% | 40% | 0% | 40% | 0% | 25 |
Nuvigil | 44% | 22% | 11% | 11% | 11% | 9 |
CCSVI (Chonic Cerebrospinal Venous Insufficiency) | 60% | 0% | 0% | 0% | 40% | 5 |
Implanted Baclofen Pump | 0% | 100% | 0% | 0% | 0% | 1 |
Plasma Exchange | 0% | 67% | 0% | 33% | 0% | 3 |
Campath | 0% | 50% | 0% | 50% | 0% | 2 |
Bee Sting Treatment | 0% | 0% | 0% | 100% | 0% | 1 |
Tonic Water | 0% | 0% | 0% | 100% | 0% | 1 |
Tizanidine | 0% | 61% | 0% | 22% | 17% | 18 |
IVIG | 50% | 0% | 50% | 0% | 0% | 2 |
Carbamazepine | 0% | 40% | 20% | 40% | 0% | 5 |
Hyperbaric Oxygenation | 0% | 50% | 17% | 17% | 17% | 6 |
4-Aminopyridine | 8% | 23% | 8% | 54% | 8% | 13 |
Novantrone | 18% | 9% | 18% | 45% | 9% | 11 |
Cytoxan/Endoxan | 0% | 0% | 100% | 0% | 0% | 3 |
Amantadine | 8% | 18% | 8% | 50% | 18% | 40 |
Rebif | 8% | 16% | 21% | 41% | 14% | 63 |
Betaseron | 0% | 9% | 24% | 53% | 15% | 34 |
Predictors
Below is the change in Multiple Sclerosis seen after the predictor is higher than average.

Don't see what you're looking for?
Create a study and help us eradicate suffering!
Predictors Label
Predictors
of
Below is the change in after the listed predictor is higher than average.
(Math.abs(a['change']) < Math.abs(b['change'])) ? 1 : -1)" title="Click to put the results with the largest observed change at the top">
Sort by Effect Size
(a['number_of_days'] < b['number_of_days']) ? 1 : -1)" title="Click to put the results with the most supporting data points at the top.">
Sort by Confidence
Multiple Sclerosis Info
Property | Value |
---|---|
Variable Name | Multiple Sclerosis |
Aggregation Method | MEAN |
Analysis Performed At | 2020-03-02 |
Duration of Action | 24 hours |
Maximum Allowed Value | 5 out of 5 |
Minimum Allowed Value | 1 out of 5 |
Number of Aggregate Predictors | 0 |
Number of Aggregate Outcomes | 0 |
Number of Measurements | 0 |
Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
Public | true |
Onset Delay | 0 seconds |
Unit | 1 to 5 Rating |
User Variables | 0 |
Variable Category | Symptoms |
Variable ID | 86869 |